Observational study identifies factors influencing long-term anamorelin use in cancer cachexia, suggesting personalized patient care.
Lower mGPS, and better ECOG PS were associated with longer continuation of anamorelin, whereas patients with gastric cancer showed a tendency toward shorter duration. These findings provide guidance for patient selection and tailored supportive care in clinical practice.
No takes yet. Share an insight, caveat, or question.
Kanbayashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: